Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 3Completed 2Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 1475Neoplasms 996Colorectal Neoplasms 830Carcinoma, Non-Small-Cell Lung 724Carcinoma, Hepatocellular 682Stomach Neoplasms 646Lung Neoplasms 583Prostatic Neoplasms 543Pancreatic Neoplasms 457Rectal Neoplasms 338Uterine Cervical Neoplasms 303Colonic Neoplasms 295Neoplasm Metastasis 289Ovarian Neoplasms 285Esophageal Neoplasms 279Recurrence 276Leukemia, Myeloid, Acute 253Head and Neck Neoplasms 240Multiple Myeloma 232Brain Neoplasms 203Polycystic Ovary Syndrome 200Nasopharyngeal Carcinoma 198Melanoma 198Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Urinary Bladder Neoplasms 191Lymphoma 178Liver Neoplasms 178Endometrial Neoplasms 159Motor Activity 147Lymphoma, Large B-Cell, Diffuse 140

Interventions

ganglioside, GD2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × OTHER × Gaucher Disease × Clear all
NCT04637503 2020-11-19

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Shenzhen Geno-Immune Medical Institute

Phase 1/2 Unknown
100 enrolled
CNS

Gaucher Disease, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡